Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Erin Crown

Physician Assistant State College, PA Physician Assistant

NPI 1831535780 CMS profile 10738977

1951 Pine Hall Rd Ste 225, State College, PA 16801

Open in the dashboard

General payments

$1,239,691

2,461 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$308,003 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Erin Crown of State College, PA is reported in the CMS Open Payments database as having received $1,239,691 across 2,461 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $308,003 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $362,228 582
2024 General $294,130 560
2023 General $361,220 685
2022 General $201,866 531
2021 General $20,248 103

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Crown
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Erin Crown were reported at $362,228. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Erin Crown Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $20,248 $132 $37–$438 $132
2022 $201,866 $155 $48–$522 $149
2023 $361,220 $167 $52–$557 $160
2024 $294,130 $178 $55–$600 $164
2025 $362,228 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ITI, Inc. $395,467 645 payments
  2. Otsuka America Pharmaceutical, Inc. $269,961 657 payments
  3. Janssen Pharmaceuticals, Inc $208,687 399 payments
  4. Axsome Therapeutics, Inc. $147,002 220 payments
  5. Neurocrine Biosciences, Inc. $89,285 130 payments
  6. E.R. Squibb & Sons, L.L.C. $78,199 101 payments
  7. Supernus Pharmaceuticals, Inc. $21,247 80 payments
  8. H. Lundbeck A S $10,088 5 payments
  9. Janssen Scientific Affairs, LLC $4,840 4 payments
  10. Janssen Global Services, LLC $4,781 8 payments
  11. Other $10,135 212 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $694,397 388 payments
  2. Travel and Lodging $222,399 823 payments
  3. Consulting Fee $181,810 89 payments
  4. Honoraria $97,130 35 payments
  5. Food and Beverage $43,908 1,125 payments
  6. Education $47 1 payment
Products named General payments · program years 2021–2025
  1. CAPLYTA Psychiatry $274,624 490 payments
  2. SPRAVATO $157,973 327 payments
  3. Auvelity $146,938 219 payments
  4. ABILIFY MAINTENA $140,490 316 payments
  5. REXULTI $136,763 348 payments
  6. CAPLYTA Psychiatry $120,842 155 payments
  7. INGREZZA $88,861 122 payments
  8. ABILIFY ASIMTUFII $64,704 141 payments
  9. INVEGA SUSTENNA $60,018 84 payments
  10. INVEGA TRINZA $58,559 68 payments
  11. Other $65,818 391 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 45 drugs

Part D claims

1,721

Median for Physician Assistant: 241

Drug cost

$414,677

Median for Physician Assistant: $4,110

Branded share of claims

23.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Abilify Asimtufii Aripiprazole Brand 31 $175,280
Abilify Maintena Aripiprazole Brand 26 $66,808
Invega Sustenna Paliperidone Palmitate Brand 18 $62,664
Caplyta Lumateperone Tosylate Brand 24 $38,456
Vraylar Cariprazine Hcl Brand 15 $21,430
Aripiprazole Generic 86 $11,370
Trintellix Vortioxetine Hydrobromide Brand 11 $4,955
Duloxetine Hcl Generic 57 $3,867
Bupropion Xl Bupropion Hcl Brand 94 $2,859
Quetiapine Fumarate Generic 54 $2,485

The 10 drugs with the highest cost, of 45 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$11,510

Medicare's payments for the services billed

Medicare patients

28

Average age 57

Services billed

83

16 women, 12 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Depression 54%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 23 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CAPLYTA
$92,507 24 —
REXULTI
$50,333 — —
ABILIFY MAINTENA
$34,988 26 —
SPRAVATO
$21,074 — —
Auvelity
$18,375 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 23 in the dashboard with a free account

Records

2,461 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record